Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CTDSPL2 divergent transcript (CTDSPL2-DT) is a non-coding RNA annotated in gene databases as transcribed from the region adjacent to the CTDSPL2 gene on human chromosome 15. Unlike CTDSPL2, which encodes a phosphatase enzyme involved in regulation of RNA polymerase II and transcription, the divergent transcript does not code for a protein and its biological functions remain unclear. There is currently no evidence that CTDSPL2-DT is involved in human disease or is targeted by any known drugs.
None described for drug targeting, since it is not a therapeutic target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CTDSPL2 divergent transcript (CTDSPL2-DT).